Most BPC-157 preclinical work uses dosages around 10 mcg/kg administered intraperitoneally or subcutaneously in rodents, with study durations ranging from single administration to 14-day periods
And heres where it gets more interesting NNMT is hyperactive in conditions like obesity & type 2 diabetes, Alzheimers & Parkinsons disease, aging in general
The study adds legitimacy to user reports of accelerated recovery timelines
Gastroenterol Clin North Am
Most side effects resolve within 2-4 weeks by starting with low concentrations and proper sun protection, but severe reactions require immediate discontinuation
Type 2 diabetes, body weight, sex, baseline fat, and cardiac responsiveness all reshape the output